医学
肺病
荟萃分析
焦虑
疾病
萧条(经济学)
系统回顾
替代医学
物理疗法
传统医学
内科学
重症监护医学
梅德林
中医药
精神科
病理
法学
经济
宏观经济学
政治学
作者
Shuang Yang,Yong Xu,Wenpan Peng,Di Han,Fanchao Feng,Zhichao Wang,Cheng Gu,Xianmei Zhou,Hailang He
标识
DOI:10.1016/j.ctcp.2021.101470
摘要
Abstract Objectives To evaluate the efficacy and safety of Chinese herbal medicine (CHM) on symptoms of depression and anxiety complicated by chronic obstructive pulmonary disease (COPD). Methods Literature from 8 electronic medical databases were searched for meta-analysis using RevMan (version 5.3) and Stata (version 12.0) software. The GRADE Pro Guideline Development Tool and TSA Viewer (version.0.9.5.10 beta) were adopted to evaluate the certainty and conclusiveness of the evidence. Results 26 studies involving 2529 participants were identified. CHM demonstrated significant lower scores on the Hamilton Depression Rating Scale, Self-Rating Depression Scale, Hamilton Anxiety Rating Scale, and Self-Rating Anxiety Scale compared to the control group without CHM. Moreover, CHM showed favorable safety. Conclusions The evidence verified the efficacy and safety of CHM on relieving depression and anxiety in COPD. However, further large-scale and rigorously designed studies are urgently warranted to strengthen the evidence.
科研通智能强力驱动
Strongly Powered by AbleSci AI